En esta página
01HUM precio
02Instantánea
03Gráfico
04Divisiones de acciones
05Acerca de
06Rendimiento
07Valoración y ratios
13Dividendos
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
HUM Humana Inc. Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 29, 2026
$388,36
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$163,11mínimo 52 semanas
$428,88máximo 52 semanas
Capitalización Bursátil (MRQ)
$77.17B
P/E (TTM)
36.7
BPA (TTM)
$10.59
Ingresos (TTM)
$145.68B
tus insignias
Rango 52S
$163–$429
Calificación del Analista
HOLD
Precio Objetivo
$424
P/E
36.7
ROE
6.8%
Margen de Beneficio Neto
0.88%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
HUM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$388.36
Capitalización Bursátil (MRQ)
$77.17B
P/E (TTM)
36.7
BPA (TTM)
$10.59
Ingresos (TTM)
$145.68B
Rendimiento div.
0.55%
ROE (TTM)
6.8%
Deuda/Capital (MRQ)
0.6
Rango 52S
$163–$429
HUM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 1 de agosto de 1991 | 3-for-2 | Adelante |
| 1 de febrero de 1984 | 6-for-5 | Adelante |
| 1 de febrero de 1983 | 4-for-3 | Adelante |
| 1 de febrero de 1982 | 3-for-2 | Adelante |
Acerca de Humana Inc. Common Stock Descripción general de la empresa de Wikipedia
Humana Inc. (NYSE: HUM), fundada en el año 1961 en Louisville, Kentucky, es una corporación empresarial que comercializa y administra seguros de salud. Con un conjunto de 11,5 millones de clientes en Estados Unidos, la compañía es la mayor en términos de beneficio del estado de Kentucky e integrante de la lista Fortune 100. Asimismo tiene una capitalización bursátil de más de 13 mil millones de dólares, beneficios por valor de 25,2 mil millones y posee 26 000 empleados en todo Norteamérica. Humana comercializa sus seguros de salud en los 50 estados de EE. UU., Washington D. C. y Puerto Rico, poseyendo además intereses económicos en Europa Occidental.
Historia
1961-1993: Hospitales y residencias de la tercera edad
La compañía fue fundada por David A. Jones, Sr. y Wendell Cherry como empresa propietaria de residencias de la tercera edad en 1961. Entonces llamada Extendicare, llegó a ser la mayor empresa de este tipo en los Estados Unidos, para dejar esta actividad de lado y centrarse en la compra de hospitales en 1972. Llegó a ser la mayor compañía hospitalaria del mundo en la década de los ochenta.
El nombre de la compañía cambió a Humana Inc. en 1974. Humana sufrió un tremendo crecimiento en los años venideros, en parte como consecuencia de la toma de control de American Medicorp Inc. en el año 1978, que tuvo como consecuencia que la empresa doblara su tamaño. Durante la segunda mitad de los años setenta, la empresa volcó sus esfuerzos en una estrategia de construcción y apertura rápida de hospitales en un mes. Durante este boom de la construcción, Humana desarrolló el modelo de doble pasillo para la construcción de hospitales. Este diseño altamente eficaz redujo la distancia entre pacientes y enfermeros localizando el servicio sanitario en el interior del edificio con las habitaciones de los pacientes rodeando el perímetro.
Humana trajo la investigación pionera del corazón artificial de la mano de los doctores Robert Jarvik y William DeVries, inventor y cirujano del primer corazón de este tipo que se implantó en la Universidad de Utah en 1982, para crear el Humana Heart Institute en Louisville en 1985.
Durante la última década del siglo XX Humana separó sus hospitales de sus operaciones relativas a la aseguración médica.
1984-presente: Seguros de salud
Durante el desarrollo del sistema sanitario de EE. UU. en la década de los ochenta, Humana creó y comenzó a comercializar seguros de salud. Por otro lado en 1998, el grupo United Healthcare intentó adquirir la compañía, sin embargo el esfuerzo fracasó cuando se dio a conocer las pérdidas trimestraes de United por valor de casi mil millones de dólares.
En el año 2001, Humana se unió en colaboración con Navigy, Inc. (subsidiaria de la también empresa aseguradora Blue Cross and Blue Shield Association of Florida, Inc.) para lanzar Availity, un servicio que facilita los trámites entre profesionales médicos de Florida, usuarios de los planes de salud y aseguradoras.
En 2005, la compañía pactó un acuerdo empresarial con el grupo Virgin, ofreciendo incentivos financieros a los asegurados para obtener un estilo de vida saludable en estos.
El Business Health Care Group of Southeast Wisconsin (en español, Grupo de Sanitario del Sureste de Wisconsin) escogió a Humana como socio administrativo para ayudar a reducir los costes sanitarios.
Humana lanzó en 2006 el servicio RightSource, una farmacia por correo a domicilio que opera en todo EE. UU.
Adquisiciones
La siguiente lista representa algunas de las mayores adquisiciones realizadas por Humana desde 1990 en EE. UU.
Fuente: Wikipedia, CC BY-SA 4.0 · Ver en Wikipedia ↗
sectorHealth Care
industriaHealth Care
empleados67 060
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$129.66B2016-12-31 → 2025-12-31
BPA$9.842016-12-31 → 2025-12-31
Flujo de caja libre$375M2016-12-31 → 2025-12-31
Margen neto0.88%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | HUM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 36.7promedio 5A ≈23.6 | ≈23.6 | 36.3 | Sobrevalorado | |
| P/S (TTM) | 0.5promedio 5A ≈0.7 | ≈0.7 | 0.7 | Infravalorado | |
| P/C (MRQ) | 4.0promedio 5A ≈4.6 | ≈4.6 | 3.9 | Valor razonable | |
| EV / EBITDA | 25.8promedio 5A ≈19.0 | ≈19.0 | 16.1 | Valor razonable | |
| Precio / FCF (TTM) | 39.6promedio 5A ≈54.2 | ≈54.2 | · | · | |
| Precio / Flujo de Caja (TTM) | 30.4promedio 5A ≈29.3 | ≈29.3 | 15.6 | Sobrevalorado | |
| EV / Ingresos (TTM) | 0.4promedio 5A ≈0.6 | ≈0.6 | · | · | |
| EV / FCF (TTM) | 33.5promedio 5A ≈46.5 | ≈46.5 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 4.3promedio 5A ≈14.5 | ≈14.5 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | HUM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | 1.9%promedio 5A ≈3.2% | ≈3.2% | 3.5% | Débil | |
| EBITDA Margin (Margen EBITDA) | 2.1%promedio 5A ≈3.2% | ≈3.2% | 3.7% | Débil | |
| Margen antes de impuestos (TTM) | 1.1%promedio 5A ≈2.7% | ≈2.7% | 2.8% | Débil | |
| Margen de Beneficio Neto (TTM) | 0.88%promedio 5A ≈2.2% | ≈2.2% | 2.9% | Débil | |
| ROA (TTM) | 2.4%promedio 5A ≈4.9% | ≈4.9% | 3.0% | Débil | |
| ROE (TTM) | 6.8%promedio 5A ≈13.3% | ≈13.3% | 10.1% | Débil | |
| ROIC | 7.4%promedio 5A ≈9.7% | ≈9.7% | 8.0% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | HUM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.6promedio 5A ≈0.7 | ≈0.7 | 0.7 | Baja deuda | |
| Ratio corriente (MRQ) | 1.7promedio 5A ≈1.7 | ≈1.7 | 1.7 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 1.3promedio 5A ≈1.3 | ≈1.3 | 1.3 | En línea | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.6promedio 5A ≈0.7 | ≈0.7 | 0.7 | Baja deuda |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | HUM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 10.1%promedio 5A ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 11.8%promedio 5A ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 10.9% | · | · | · | |
| EPS YoY (EPS interanual) | -1.4%promedio 5A ≈-14.8% | ≈-14.8% | · | · | |
| Net Income YoY (Beneficio Neto interanual) | -1.6%promedio 5A ≈-16.3% | ≈-16.3% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | -23.6%promedio 5A ≈-18.4% | ≈-18.4% | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | -24.9%promedio 5A ≈-20.0% | ≈-20.0% | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | -18.8% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | HUM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 2.7promedio 5A ≈2.4 | ≈2.4 | 2.4 | En línea | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 43.4promedio 5A ≈52.0 | ≈52.0 | 16.3 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.9M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo0.55%
Ratio de Pago36.2%
Pago anualizado≈$3.54
CAGR de Dividendos a 5 años≈7.2%
| Fecha ex-dividendo | Monto | Moneda | Rendimiento |
|---|---|---|---|
| Jun 26, 2026 | $0,89 | USD | ≈0.92% |
| Mar 27, 2026 | $0,89 | USD | ≈2.1% |
| Dic 26, 2025 | $0,89 | USD | ≈1.4% |
| Sep 26, 2025 | $0,89 | USD | ≈1.4% |
| Jun 27, 2025 | $0,89 | USD | ≈1.5% |
| Mar 28, 2025 | $0,89 | USD | ≈1.3% |
| Dic 31, 2024 | $0,89 | USD | ≈1.4% |
| Sep 30, 2024 | $0,89 | USD | ≈1.1% |
| Jun 28, 2024 | $0,89 | USD | ≈0.95% |
| Mar 27, 2024 | $0,89 | USD | ≈1.0% |
| Dic 28, 2023 | $0,89 | USD | ≈0.78% |
| Sep 28, 2023 | $0,89 | USD | ≈0.70% |
| Jun 29, 2023 | $0,89 | USD | ≈0.75% |
| Mar 30, 2023 | $0,89 | USD | ≈0.67% |
| Dic 29, 2022 | $0,79 | USD | ≈0.61% |
| Sep 29, 2022 | $0,79 | USD | ≈0.62% |
| Jun 29, 2022 | $0,79 | USD | ≈0.64% |
| Mar 30, 2022 | $0,79 | USD | ≈0.66% |
| Dic 30, 2021 | $0,70 | USD | ≈0.60% |
| Sep 29, 2021 | $0,70 | USD | ≈0.69% |
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
6.5%
Próximo informe
Nov 06, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 29, 2026 | $7.61 | $7.29 | 4.3% |
| 31 de marzo de 2026 | $10.31 | $10.29 | 0.21% | |
| 31 de diciembre de 2025 | $-3.96 | $-4.05 | 2.1% | |
| 30 de septiembre de 2025 | $3.24 | $2.85 | 13.8% | |
| 30 de junio de 2025 | $6.27 | $5.98 | 4.9% | |
| 31 de marzo de 2025 | $11.58 | $10.17 | 13.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $88.85 | $82.40 | $81.85 | $77.07 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $1073.15 | $974.29 | $854.81 | $730.72 | $641.94 | $580.06 | $481.63 | $411.20 | $369.32 | $360.32 | $359.19 | $311.15 | |
| Cash Flow / Share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 | $5.74 | $10.38 | |
| Cash / Share | $21.14 | $11.18 | $23.62 | $25.47 | · | · | · | · | · | · | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $1.16 | $1.15 | $1.11 | |
| Dividend Paid / Share | $3.54 | $3.54 | $3.44 | $3.06 | $2.73 | $2.43 | $2.15 | $1.90 | $1.49 | $1.16 | $1.14 | $1.10 | |
| EPS (TTM) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | · | 120,273,000 | 120,539,000 | 120,666,000 | · | 120,405,000 | 120,445,000 | 120,978,000 | · | 123,426,000 | 124,574,000 | 125,005,000 | · | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | · | 120,745,000 | 120,745,000 | 120,844,000 | · | 120,764,000 | 120,665,000 | 121,268,000 | · | 123,983,000 | 125,109,000 | 125,564,000 | · | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $96.68 | $93.50 | · | $93.21 | $91.76 | $89.33 | · | $88.39 | $83.89 | $81.18 | · | $85.30 | $84.72 | $83.44 | · | $82.13 | |
| Revenue / Share | $337.37 | $328.61 | · | $270.40 | $268.23 | $265.73 | · | $243.43 | $244.81 | $244.18 | · | $213.12 | $213.79 | $212.98 | · | $179.02 | |
| Cash Flow / Share | · | $10.39 | · | · | · | $2.74 | · | · | · | $3.49 | · | · | · | $53.26 | · | · | |
| Cash / Share | $34.69 | $24.91 | · | $27.11 | $20.33 | $21.39 | · | $25.74 | $27.68 | $29.74 | · | $76.24 | $81.60 | $69.14 | · | $68.24 | |
| Dividend / Share | $0.89 | $0.89 | $0.89 | · | · | $0.89 | $0.89 | · | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | · | · | · | · | · | · | |
| EPS (TTM) | $10.59 | $9.37 | · | $10.70 | $13.06 | $14.17 | · | $11.47 | $14.20 | $16.24 | · | $24.16 | $26.84 | $24.66 | · | $22.05 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.68B | $137.20B | · | $126.36B | $123.11B | $120.26B | · | $115.01B | $112.04B | $109.24B | · | $102.35B | $98.73B | $95.64B | · | $91.48B | |
| Net Income TTM | $1.28B | $1.13B | · | $1.29B | $1.58B | $1.71B | · | $1.36B | $1.71B | $1.99B | · | $3.02B | $3.38B | $3.12B | · | $2.81B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 37.5 | 18.5 | · | 24.3 | 18.7 | 18.7 | · | 27.6 | 26.3 | 21.3 | · | 20.1 | 16.7 | 19.7 | · | 22.0 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 0.54% | 1.2% | · | 0.83% | 0.88% | 0.82% | · | 0.69% | 0.59% | 0.64% | · | 0.44% | 0.46% | 0.42% | · | 0.40% | |
| Earnings Yield | 2.7% | 5.4% | · | 4.1% | 5.3% | 5.4% | · | 3.6% | 3.8% | 4.7% | · | 5.0% | 6.0% | 5.1% | · | 4.5% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · | |
| Annual Payout | $430M | $429M | · | $429M | $429M | $430M | · | $434M | $436M | $440M | · | $421M | $412M | $401M | · | $382M |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Margen Operativo % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Beneficio neto | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EPS Diluido | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Ratio corriente | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Ratio Rápido | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $375M | $2.39B | $2.98B | $3.47B | $946M |
Propietarios institucionales (13F) 1 038 declarantes · $52.7B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
1 038
Valor en tenencia
$52.7B
Nuevas posiciones
248
Posiciones cerradas
85
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 248 (+126 vs trimestre anterior) | 85 (-76 vs trimestre anterior) | 325 (+68 vs trimestre anterior) | 288 (-56 vs trimestre anterior) | +3.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Dodge & Cox | $4 345 737 744 | 10 940 380 | 8,25% | Acciones |
| BlackRock, Inc. | $4 138 159 785 | 10 417 803 | 7,85% | Acciones |
| VANGUARD GROUP INC | $3 652 890 202 | 14 261 860 | 6,93% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 115 642 737 | 7 843 620 | 5,91% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 311 405 702 | 5 818 956 | 4,39% | Acciones |
| STATE STREET CORP | $2 172 441 313 | 5 457 072 | 4,12% | Acciones |
| PZENA INVESTMENT MANAGEMENT LLC | $1 749 013 682 | 4 403 136 | 3,32% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1 664 784 292 | 3 578 245 | 3,16% | Acciones |
| EAGLE CAPITAL MANAGEMENT LLC | $1 528 010 749 | 3 846 762 | 2,90% | Acciones |
| Sessa Capital IM, L.P. | $1 480 732 883 | 3 727 740 | 2,81% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 337 386 742 | 3 369 757 | 2,54% | Acciones |
| JPMORGAN CHASE & CO | $1 257 951 102 | 3 234 637 | 2,39% | Acciones |
| FMR LLC | $1 157 405 236 | 2 913 763 | 2,20% | Acciones |
| Capital International Investors | $950 462 637 | 2 392 826 | 1,80% | Acciones |
| GOLDMAN SACHS GROUP INC | $913 562 254 | 2 299 889 | 1,73% | Acciones |
| NAYA CAPITAL MANAGEMENT UK LTD | $728 407 339 | 1 833 763 | 1,38% | Acciones |
| NORGES BANK | $694 505 009 | 1 748 414 | 1,32% | Acciones |
| Invesco Ltd. | $587 403 999 | 1 478 788 | 1,11% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544 521 489 | 1 370 831 | 1,03% | Acciones |
| MORGAN STANLEY | $535 876 914 | 1 349 066 | 1,02% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $445 839 059 | 1 122 669 | 0,85% | Acciones |
| Capital Research Global Investors | $443 462 035 | 1 116 990 | 0,84% | Acciones |
| NORTHERN TRUST CORP | $442 978 948 | 1 115 198 | 0,84% | Acciones |
| Slate Path Capital LP | $428 969 795 | 1 079 930 | 0,81% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $423 436 520 | 1 066 000 | 0,80% | Opción de venta |
| Capital World Investors | $406 119 738 | 1 022 425 | 0,77% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $399 841 652 | 1 006 600 | 0,76% | Opción de compra |
| Newport Trust Company, LLC | $384 768 345 | 968 653 | 0,73% | Acciones |
| CITADEL ADVISORS LLC | $363 376 856 | 914 800 | 0,69% | Opción de compra |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348 908 912 | 878 377 | 0,66% | Acciones |
| Legal & General Group Plc | $329 760 125 | 830 170 | 0,63% | Acciones |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314 921 577 | 792 814 | 0,60% | Acciones |
| CITADEL ADVISORS LLC | $310 904 094 | 782 700 | 0,59% | Opción de venta |
| Allianz Asset Management GmbH | $307 098 329 | 773 119 | 0,58% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $304 014 312 | 765 355 | 0,58% | Acciones |
| BANK OF AMERICA CORP /DE/ | $279 490 113 | 703 615 | 0,53% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $267 791 027 | 674 163 | 0,51% | Acciones |
| Maple Rock Capital Partners Inc. | $249 553 862 | 628 251 | 0,47% | Acciones |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245 555 446 | 618 185 | 0,47% | Acciones |
| Bank of New York Mellon Corp | $238 144 113 | 599 527 | 0,45% | Acciones |
| GOLDMAN SACHS GROUP INC | $232 333 978 | 584 900 | 0,44% | Opción de compra |
| MARSHALL WACE, LLP | $216 873 381 | 545 978 | 0,41% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $189 649 820 | 1 093 776 | 0,36% | Acciones |
| CITADEL ADVISORS LLC | $178 360 519 | 449 022 | 0,34% | Acciones |
| High Ground Investment Management LLP | $177 941 848 | 447 968 | 0,34% | Acciones |
| 1832 Asset Management L.P. | $176 401 430 | 444 090 | 0,33% | Acciones |
| BCV Asset Management Inc. | $173 695 656 | 445 719 | 0,33% | Acciones |
| Nuveen, LLC | $167 646 743 | 422 051 | 0,32% | Acciones |
| Holocene Advisors, LP | $165 040 541 | 415 489 | 0,31% | Acciones |
| DEUTSCHE BANK AG\ | $163 345 207 | 411 221 | 0,31% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| David A. Jones ×2 presentaciones | 12 de noviembre de 2003 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 79 insiders · 48 directivos · 29 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 1 de mayo de 2026 A | 63 938 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 de febrero de 2024 A | 110 130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 1 de mayo de 2026 A | 39 637 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 de diciembre de 2024 J | 20 165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 de febrero de 2021 A | 24 342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 9 de mayo de 2014 G | 14 916 | 0 | 0 | $0 |
| Aaron Martin | President, Medicare Advantage | 1 de mayo de 2026 A | 25 237 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 1 de mayo de 2026 A | 25 407 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 1 de mayo de 2026 A | 22 088 | 1 | 0 | $150 012 |
| George Renaudin II | President, Insurance | 31 de marzo de 2026 J | 16 075 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 de febrero de 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 de diciembre de 2022 M | 3 983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 de diciembre de 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 de febrero de 2014 A | 105 443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 de marzo de 2017 J | 34 668 | 0 | 0 | $0 |
| Shantanu Nundy | Chief Medical Officer | 1 de septiembre de 2026 A | 2 549 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 1 de mayo de 2026 A | 17 176 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 1 de mayo de 2026 A | 20 026 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 1 de mayo de 2026 A | 27 405 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 de febrero de 2026 F | 7 484 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 de febrero de 2025 A | 16 717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 de diciembre de 2024 G | 7 111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 de diciembre de 2024 M | 14 015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 de febrero de 2024 A | 11 723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 de febrero de 2023 F | 3 687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 1 de mayo de 2022 M | 4 294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 de marzo de 2022 J | 5 723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 de febrero de 2022 F | 6 014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 de marzo de 2021 G | 8 168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 de diciembre de 2019 M | 18 092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 de diciembre de 2019 M | 6 339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 de febrero de 2019 A | 9 774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 de febrero de 2019 M | 10 791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 de diciembre de 2018 M | 11 136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 de diciembre de 2018 M | 6 476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 de marzo de 2017 M | 4 361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 de febrero de 2014 A | 1 101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 de febrero de 2014 A | 15 946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 de junio de 2013 M | 19 347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 de diciembre de 2012 G | 2 287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 de abril de 2012 F | 11 946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 de febrero de 2012 A | 23 280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 4 de febrero de 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 de marzo de 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 de febrero de 2008 F | 13 836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 de diciembre de 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 de febrero de 2007 M | 57 548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 6 de enero de 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Consejero | 30 de septiembre de 2026 A | 19 448 | 0 | 0 | $0 |
| Paul John Smith | Consejero | 1 de agosto de 2026 A | 544 | 0 | 0 | $0 |
| Robert Stuart Field | Consejero | 1 de mayo de 2026 A | 852 | 0 | 0 | $0 |
| Jorge S. Mesquita | Consejero | 2 de enero de 2026 A | 4 127 | 0 | 0 | $0 |
| Frank A Damelio | Consejero | 2 de enero de 2026 A | 20 634 | 0 | 0 | $0 |
| Raquel C. Bono | Consejero | 31 de diciembre de 2025 A | 397 | 0 | 0 | $0 |
| Wayne A.I. Frederick | Consejero | 31 de diciembre de 2025 A | 440 | 0 | 0 | $0 |
| Marcy S Klevorn | Consejero | 31 de diciembre de 2025 A | 436 | 0 | 0 | $0 |
| John W Garratt | Consejero | 31 de diciembre de 2025 A | 1 685 | 0 | 0 | $0 |
| David T Feinberg | Consejero | 31 de diciembre de 2025 A | 1 207 | 0 | 0 | $0 |
| Karen Katz | Consejero | 31 de diciembre de 2025 A | 590 | 0 | 0 | $0 |
| Brad D Smith | Consejero | 31 de diciembre de 2024 A | 1 169 | 0 | 0 | $0 |
| William J. Mcdonald | Consejero | 2 de enero de 2024 A | 2 276 | 0 | 0 | $0 |
| JONES DAVID A JR/KY | Consejero | 28 de febrero de 2023 G | 32 440 | 0 | 0 | $0 |
| OBRIEN JAMES J /KY | Consejero | 3 de enero de 2023 A | 1 794 | 0 | 0 | $0 |
| Marissa T Peterson | Consejero | 3 de enero de 2022 A | 2 044 | 0 | 0 | $0 |
| Frank Bisignano | Consejero | 4 de enero de 2021 A | 2 727 | 0 | 0 | $0 |
| Webster Roy Dunbar | Consejero | 31 de diciembre de 2019 A | 2 880 | 0 | 0 | $0 |
| Karen B Desalvo | Consejero | 2 de enero de 2019 A | 634 | 0 | 0 | $0 |
| David Nash | Consejero | 2 de enero de 2019 A | 112 | 0 | 0 | $0 |
| William Mitchell | Consejero | 31 de diciembre de 2018 A | 688 | 0 | 0 | $0 |
| Michael B Mccallister | Consejero | 31 de diciembre de 2013 M | 113 885 | 0 | 0 | $0 |
| Ann W Reynolds | Consejero | 15 de mayo de 2011 M | 39 727 | 0 | 0 | $0 |
| James O Robbins | Consejero | 3 de enero de 2007 A | · | 0 | 0 | $0 |
| HALL JOHN R /KY | Consejero | 3 de enero de 2006 A | 22 423 | 0 | 0 | $0 |
| JONES DAVID A SR/KY | Consejero | 5 de abril de 2005 G | 4 777 524 | 0 | 0 | $0 |
| Michael E Gellert | Consejero | 3 de enero de 2005 A | 60 237 | 0 | 0 | $0 |
| Irwin Lerner | Consejero | 2 de enero de 2004 A | 30 637 | 0 | 0 | $0 |
| Frederick John Crawford | · | 1 de agosto de 2026 A | 544 | 0 | 0 | $0 |
| Gordon Smith | · | 31 de diciembre de 2025 A | 765 | 0 | 0 | $0 |
| James H Bloem | · | 7 de noviembre de 2013 M | 30 326 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 143 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IHF · iShares Trust | 4,63% | 151 582 SH | 11 de septiembre de 2026 | Diario |
| FMTM · EA Series Trust | 3,07% | 21 303 NS | 31 de julio de 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,57% | 1 854 NS | 31 de julio de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,35% | 103 450 SH | 2 de octubre de 2026 | Diario |
| SRHQ · Elevation Series Trust | 2,31% | 13 473 NS | 31 de julio de 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,75% | 225 NS | 31 de julio de 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,71% | 2 014 NS | 31 de julio de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 35 951 SH | 2 de octubre de 2026 | Diario |
| NUMV · Nushares ETF Trust | 1,39% | 16 939 NS | 31 de julio de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,16% | 290 NS | 31 de julio de 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,88% | 32 276 NS | 31 de julio de 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771 237 SH | 19 de agosto de 2026 | Diario |
| IYH · iShares Trust | 0,78% | 70 303 SH | 11 de septiembre de 2026 | Diario |
| JOET · Virtus ETF Trust II | 0,74% | 4 940 NS | 31 de julio de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,74% | 4 248 NS | 31 de julio de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 181 374 SH | 2 de octubre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,70% | 360 880 SH | 19 de agosto de 2026 | Diario |
| PDP · Invesco Exchange-Traded Fund Trust | 0,70% | 27 208 SH | 2 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,63% | 57 108 NS | 31 de julio de 2026 | N-PORT |
| IXJ · iShares Trust | 0,61% | 63 215 SH | 11 de septiembre de 2026 | Diario |
| CURE · Direxion Shares ETF Trust | 0,50% | 2 362 NS | 31 de julio de 2026 | N-PORT |
| IWS · iShares Trust | 0,47% | 179 478 SH | 11 de septiembre de 2026 | Diario |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2 601 869 SH | 19 de agosto de 2026 | Diario |
| IMCV · iShares Trust | 0,40% | 11 586 SH | 11 de septiembre de 2026 | Diario |
| MTUM · iShares Trust | 0,37% | 227 558 SH | 11 de septiembre de 2026 | Diario |
| IWR · iShares Trust | 0,35% | 492 212 SH | 11 de septiembre de 2026 | Diario |
| PRF · Invesco Exchange-Traded Fund Trust | 0,34% | 88 063 SH | 2 de octubre de 2026 | Diario |
| IMCB · iShares Trust | 0,34% | 14 123 SH | 11 de septiembre de 2026 | Diario |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,33% | 10 420 000 | 2 de octubre de 2026 | Diario |
| FFLC · FIDELITY COVINGTON TRUST | 0,32% | 10 722 NS | 31 de julio de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 8 116 SH | 2 de octubre de 2026 | Diario |
| IMCG · iShares Trust | 0,27% | 27 157 SH | 11 de septiembre de 2026 | Diario |
| XOEF · iShares Trust | 0,27% | 151 SH | 11 de septiembre de 2026 | Diario |
| VLUE · iShares Trust | 0,26% | 62 879 SH | 11 de septiembre de 2026 | Diario |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,25% | 320 000 | 2 de octubre de 2026 | Diario |
| SIZE · iShares Trust | 0,24% | 2 599 SH | 11 de septiembre de 2026 | Diario |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 8 027 000 | 2 de octubre de 2026 | Diario |
| ROUS · Lattice Strategies Trust | 0,23% | 4 462 NS | 31 de julio de 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,22% | 9 983 000 | 2 de octubre de 2026 | Diario |
| EUSA · iShares, Inc. | 0,22% | 10 324 SH | 11 de septiembre de 2026 | Diario |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 26 395 NS | 31 de julio de 2026 | N-PORT |
| CATH · Global X Funds | 0,21% | 7 419 NS | 31 de julio de 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,20% | 479 438 SH | 19 de agosto de 2026 | Diario |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 487 833 SH | 2 de octubre de 2026 | Diario |
| EVUS · iShares Trust | 0,19% | 1 842 SH | 11 de septiembre de 2026 | Diario |
| USXF · iShares Trust | 0,19% | 7 125 SH | 11 de septiembre de 2026 | Diario |
| ESMV · iShares Trust | 0,19% | 37 SH | 11 de septiembre de 2026 | Diario |
| SUSA · iShares Trust | 0,19% | 19 078 SH | 11 de septiembre de 2026 | Diario |
| ACVF · ETF Opportunities Trust | 0,19% | 790 NS | 31 de julio de 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,18% | 1 140 642 SH | 19 de agosto de 2026 | Diario |
| DFLV · Dimensional ETF Trust | 0,18% | 32 943 NS | 31 de julio de 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 3 921 NS | 31 de julio de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 3 648 SH | 19 de agosto de 2026 | Diario |
| DFSU · Dimensional ETF Trust | 0,17% | 10 472 NS | 31 de julio de 2026 | N-PORT |
| IVE · iShares Trust | 0,16% | 200 080 SH | 11 de septiembre de 2026 | Diario |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,16% | 27 648 SH | 19 de agosto de 2026 | Diario |
| IUSV · iShares Trust | 0,15% | 104 740 SH | 11 de septiembre de 2026 | Diario |
| VEGN · ETF Series Solutions | 0,15% | 709 NS | 31 de julio de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,14% | 60 086 NS | 31 de julio de 2026 | N-PORT |
| SUSL · iShares Trust | 0,14% | 4 238 SH | 11 de septiembre de 2026 | Diario |
| FYEE · Fidelity Greenwood Street Trust | 0,14% | 839 NS | 31 de julio de 2026 | N-PORT |
| DSI · iShares Trust | 0,14% | 18 418 SH | 11 de septiembre de 2026 | Diario |
| IQSU · New York Life Investments ETF Trust | 0,14% | 1 230 NS | 31 de julio de 2026 | N-PORT |
| CHRI · Global X Funds | 0,13% | 29 NS | 31 de julio de 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 72 504 SH | 19 de agosto de 2026 | Diario |
| IWD · iShares Trust | 0,13% | 267 199 SH | 11 de septiembre de 2026 | Diario |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,12% | 3 809 000 | 2 de octubre de 2026 | Diario |
| NULV · Nushares ETF Trust | 0,11% | 6 797 NS | 31 de julio de 2026 | N-PORT |
| ESGU · iShares Trust | 0,11% | 47 962 SH | 11 de septiembre de 2026 | Diario |
| DGRO · iShares Trust | 0,10% | 111 232 SH | 11 de septiembre de 2026 | Diario |
| EGLE · Global X Funds | 0,10% | 6 NS | 31 de julio de 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,10% | 3 NS | 31 de julio de 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,10% | 6 NS | 31 de julio de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1 886 SH | 2 de octubre de 2026 | Diario |
| TOPC · iShares Trust | 0,09% | 72 SH | 11 de septiembre de 2026 | Diario |
| ILCV · iShares Trust | 0,08% | 2 783 SH | 11 de septiembre de 2026 | Diario |
| XVV · iShares Trust | 0,08% | 1 375 SH | 11 de septiembre de 2026 | Diario |
| VV · VANGUARD INDEX FUNDS | 0,08% | 140 219 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,08% | 27 152 SH | 19 de agosto de 2026 | Diario |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,08% | 3 447 SH | 2 de octubre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,08% | 100 648 NS | 31 de julio de 2026 | N-PORT |
| XTR · Global X Funds | 0,08% | 10 NS | 31 de julio de 2026 | N-PORT |
| IVV · iShares Trust | 0,07% | 1 513 176 SH | 11 de septiembre de 2026 | Diario |
| ILCB · iShares Trust | 0,07% | 2 328 SH | 11 de septiembre de 2026 | Diario |
| XCLR · Global X Funds | 0,07% | 7 NS | 31 de julio de 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,07% | 3 119 147 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,07% | 3 812 375 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,07% | 19 809 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,07% | 10 113 SH | 19 de agosto de 2026 | Diario |
| PBP · Invesco Exchange-Traded Fund Trust | 0,07% | 715 SH | 2 de octubre de 2026 | Diario |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,07% | 20 848 SH | 2 de octubre de 2026 | Diario |
| IYY · iShares Trust | 0,07% | 5 172 SH | 11 de septiembre de 2026 | Diario |
| IWB · iShares Trust | 0,07% | 82 919 SH | 11 de septiembre de 2026 | Diario |
| XYLD · Global X Funds | 0,07% | 6 091 NS | 31 de julio de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,07% | 6 112 NS | 31 de julio de 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 16 615 NS | 31 de julio de 2026 | N-PORT |
| USCL · iShares Trust | 0,07% | 4 768 SH | 11 de septiembre de 2026 | Diario |
| VOTE · TCW ETF Trust | 0,07% | 2 035 NS | 31 de julio de 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,07% | 10 127 NS | 31 de julio de 2026 | N-PORT |
| XRMI · Global X Funds | 0,07% | 92 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,07% | 33 101 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,07% | 156 223 SH | 11 de septiembre de 2026 | Diario |
| LRGF · iShares Trust | 0,06% | 5 842 SH | 11 de septiembre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,06% | 959 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,06% | 36 333 NS | 31 de julio de 2026 | N-PORT |
| XYLG · Global X Funds | 0,06% | 111 NS | 31 de julio de 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,06% | 453 NS | 31 de julio de 2026 | N-PORT |
| ILCG · iShares Trust | 0,06% | 4 804 SH | 11 de septiembre de 2026 | Diario |
| QDPL · Pacer Funds Trust | 0,06% | 2 883 NS | 31 de julio de 2026 | N-PORT |
| TOV · EA Series Trust | 0,06% | 454 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,06% | 3 564 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,06% | 20 053 NS | 31 de julio de 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,06% | 95 SH | 2 de octubre de 2026 | Diario |
| VOXP · Advisors Series Trust | 0,06% | 9 NS | 31 de julio de 2026 | N-PORT |
| TOK · iShares Trust | 0,06% | 333 SH | 11 de septiembre de 2026 | Diario |
| HCMT · Direxion Shares ETF Trust | 0,05% | 835 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 4 948 NS | 31 de julio de 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 10 772 SH | 11 de septiembre de 2026 | Diario |
| SPXL · Direxion Shares ETF Trust | 0,05% | 9 382 NS | 31 de julio de 2026 | N-PORT |
| ACWI · iShares Trust | 0,05% | 38 539 SH | 11 de septiembre de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 196 805 SH | 19 de agosto de 2026 | Diario |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4 718 SH | 2 de octubre de 2026 | Diario |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1 504 000 SH | 11 de septiembre de 2026 | Diario |
| GLOF · iShares Trust | 0,02% | 106 SH | 11 de septiembre de 2026 | Diario |
| DYNF · BlackRock ETF Trust | 0,01% | 14 919 SH | 11 de septiembre de 2026 | Diario |
| CRBN · iShares Trust | 0,01% | 383 SH | 11 de septiembre de 2026 | Diario |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 4 397 881 SH | 19 de agosto de 2026 | Diario |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 401 850 SH | 19 de agosto de 2026 | Diario |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 932 492 SH | 19 de agosto de 2026 | Diario |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 2 391 019 SH | 19 de agosto de 2026 | Diario |
| VSGX · VANGUARD WORLD FUND | 0,00% | 54 062 SH | 19 de agosto de 2026 | Diario |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de julio de 2026 | Diario |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de julio de 2026 | Diario |
| VCEB · VANGUARD WORLD FUND | · | · | 30 de julio de 2026 | Diario |
HUM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 33 analistas
COMPRA
Objetivo mediano
$420.00
+8,1%
8 24,2%
Compra fuerte
8 24,2%
Compra
16 48,5%
Mantener
1 3,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
23 analistas · 2026-09-30Objetivo medio $423.74 +9,1%
Ahora
Precio Actual $388.36
Mín$280.00
Media$423.74
Máx$515.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Humana divests interest in end-of-life provider Gentiva valued at $900M
Yahoo Finance · 3 meses, 3 semanas atrás
Humana To Sell Gentiva Minority Stake In $900 Mln Deal
Nasdaq · 3 meses, 3 semanas atrás
Humana (HUM) Transcripción de la llamada de resultados del primer trimestre de 2026
Yahoo Finance · 5 meses atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 29, 2026